BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12377268)

  • 21. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
    Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA; Hen R; Blendy JA; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement in extracellular serotonin levels by 5-hydroxytryptophan loading after administration of WAY 100635 and fluoxetine.
    Dreshfield-Ahmad LJ; Thompson DC; Schaus JM; Wong DT
    Life Sci; 2000 Apr; 66(21):2035-41. PubMed ID: 10823343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus.
    Fuller RW; Perry KW; Hemrick-Luecke SK; Engleman E
    J Pharm Pharmacol; 1996 Jan; 48(1):68-70. PubMed ID: 8722499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain.
    Stenfors C; Yu H; Ross SB
    Neuropharmacology; 2000 Feb; 39(4):553-60. PubMed ID: 10728876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of restraint stress and anxiolytics on 5-HT turnover in rat brain.
    Mitchell SN; Thomas PJ
    Pharmacology; 1988; 37(2):105-13. PubMed ID: 2905483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences.
    Lifschytz T; Gur E; Lerer B; Newman ME
    J Neurosci Methods; 2004 Dec; 140(1-2):133-9. PubMed ID: 15589343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
    Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K
    Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A; Rivet JM; Cistarelli L; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents.
    Emmanouil DE; Papadopoulou-Daifoti Z; Hagihara PT; Quock DG; Quock RM
    Pharmacol Biochem Behav; 2006 Jun; 84(2):313-20. PubMed ID: 16828854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography.
    Pejchal T; Foley MA; Kosofsky BE; Waeber C
    Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No effect of C1473G polymorphism in the tryptophan hydroxylase 2 gene on the response of the brain serotonin system to chronic fluoxetine treatment in mice.
    Bazhenova EY; Sinyakova NA; Kulikova EA; Kazarinova IA; Bazovkina DV; Gainetdinov RR; Kulikov AV
    Neurosci Lett; 2017 Jul; 653():264-268. PubMed ID: 28579486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subchronic fluoxetine administration to rats: effects on 5-HT autoreceptor activity as measured by in vivo microdialysis.
    Dremencov E; Gur E; Lerer B; Newman ME
    Eur Neuropsychopharmacol; 2000 Jul; 10(4):229-36. PubMed ID: 10871704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.